Mesothelin/GPC3/GUCY2C-CAR-T cells

CAR-T cell therapy targeting mesothelin, GPC3, and GUCY2C · Second Affiliated Hospital of Guangzhou Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mesothelin/GPC3/GUCY2C-CAR-T cells, covering 2024-06-25 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers [Phase 1]